Stock SMMT SUMMIT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
3.38 USD -21.76% Intraday chart for Summit Therapeutics Inc. -23.87% +29.50%
May. 24 Sector Update: Health Care Stocks Decline Late Friday Afternoon MT
May. 24 Summit Therapeutics Shares Fall After Late-Stage Topline Data for Lung Cancer Treatment Announced MT

Evolution of the average Target Price on Summit Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

a76e24623d8.ag12HEpp_OrSs-vJLqK0hekzRJHtID_P0bIdqWVmsH8.DEAjeQEHztuW14b7V9XV07F-d6aLWGqm4dAtzjoM5S0sTg9mAA6Svarrrg~c91aebd13ce839ba3ceca55b4c14be5a

Analyst Recommendations on Summit Therapeutics Inc.

Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target MT
Stifel Initiates Summit Therapeutics With Buy Rating, $8 Price Target MT
Summit Therapeutics to Present Research Updates At the 31St Annual ECCMID Conference, Including A Top-Rated ePoster CI
SUMMIT THERAPEUTICS : HC Wainwright Downgrades Summit Therapeutics to Neutral from Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.652 GBP
Average target price
5.938 GBP
Spread / Average Target
+123.91%
High Price Target
6.294 GBP
Spread / Highest target
+137.35%
Low Price Target
5.581 GBP
Spread / Lowest Target
+110.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Summit Therapeutics Inc.

Citigroup
Stifel Nicolaus

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SMMT Stock
  4. Consensus Summit Therapeutics Inc.